Clinical trial
Intermuscular Coherence: A Biomarker for Early Diagnosis and Follow-up of ALS
NCT05104710 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermuscular Coherence: A Biomarker for Early Diagnosis and Follow-up of ALS
- Lead sponsor
- University of Chicago
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 31, 2021
- Completion date
- December 31, 2026
- Enrollment
- 650 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.